Investigators for this study analyzed outcomes among patients hospitalized with pulmonary arterial hypertension (PAH) who have higher risks of adverse health outcomes, in particular sepsis and septic shock.
Among hospitalized patients who have pulmonary arterial hypertension (PAH) and were admitted for sepsis or septic shock (SSS), higher incidence rates of and worse outcomes from comorbid heart failure were seen, with investigators stressing the importance of managing right ventricular strain in these patients.
Study results were published recently in BMC Pulmonary Medicine from the analysis of data on 1134 adult patients appearing in the National Readmissions Database between 2016 and 2017. Propensity score matching was on the basis of demographic, social, and clinical variables. Their mean age was 65 years, and 67% identified as female. International Classification of Diseases, Tenth Revision codes were used for SSS diagnosis identification.
“Most outcome studies in PAH focus on right heart failure,” the authors wrote. “The current literature lacks in establishing the impact of PAH in patients with SSS.”
Among patients with diagnosed PAH in this study, several chronic diseases were more common among those who also had SSS (all P < .001):
Overall, the gap in mortality (primary outcome) was determined to be not significant, at 16.5% in the patients with PAH and SSS compared with 15.1% (P = .41) among those with SSS only. However, a matching subanalysis of secondary end points determined that patients who had both more commonly had acute heart failure (24.1% vs 19.6%; P < .001), a longer hospital stay (13.5 vs 10.9 days; P < .001), and greater total hospital costs ($164,252 vs $129,185; P < .001).
Among other secondary outcomes of vasopressor use (P < .236), atrial fibrillation (P < .698), hemorrhagic stroke (P = 1), ischemic stroke (P < .246), and acute instances of myocardial infarction (P < .454) or kidney injury (P < .503), no significant differences were seen.
“Our results indicate that patients with PAH do not have a higher risk of worse clinical outcomes when admitted for sepsis or septic shock, except for acute heart failure,” the study authors concluded. “However, patients with PAH had worse resource utilization outcomes, including length of stay and hospitalization costs.”
They stressed the degree of vulnerability among patients with PAH, in particular those who are older than 50 years, due to their higher chances of comorbidities—especially of the heart. And for those in septic shock, they have an even greater risk for decompensation because of the body’s limited perfusion ability.
It is important to investigate PAH management strategies among these older patients, particularly those that must also consider contributions from sepsis. Not only can this help the patients, but it can mitigate the burden on the health care system, the study investigators emphasized.
Reference
Vasudeva R, Challa A, Tuck N, Pothuru, Vindhyal M. Hospital outcomes for patients with pulmonary arterial hypertension in sepsis and septic shock. BMC Pulm Med. Published online October 3, 2022. doi:10.1186/s12890-022-02145-1
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More